Question 1

Who are the top researchers at ISA Pharmaceuticals (Netherlands)?

Accepted Answer

Ranked on the quality score, Willem-Jan Krebber lead among researchers whose main affiliation is ISA Pharmaceuticals (Netherlands).

Question 2

What are the most cited papers from ISA Pharmaceuticals (Netherlands)?

Accepted Answer

The most cited paper from ISA Pharmaceuticals (Netherlands) is "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens" (Matthew M. Gubin et al., 2014), with 2,015 citations. Next come "CD4+ T cell help in cancer immunology and immunotherapy" (1,685) and "Therapeutic cancer vaccines" (1,589).

Question 3

Which research topics does ISA Pharmaceuticals (Netherlands) publish most on?

Accepted Answer

By volume in 2022-now: Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, vaccines and immunoinformatics approaches and Cervical Cancer and HPV Research.

Question 4

Which keywords describe research at ISA Pharmaceuticals (Netherlands)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Antigen Presentation, Cancer Immunotherapy, Immunity, Dendritic Cells, Innate Immunity, Tumor Antigen, Vaccine Adjuvants and Tumor Microenvironment.

Question 5

Which fields of science does ISA Pharmaceuticals (Netherlands) work in?

Accepted Answer

In all years, 53% of research at ISA Pharmaceuticals (Netherlands) is in Life Sciences, 46% in Health Sciences. Its largest fields are Medicine (44%), Immunology and Microbiology (40%), Biochemistry, Genetics and Molecular Biology (10%). It does 2.7× the world's share of Life Sciences.

Question 6

Is ISA Pharmaceuticals (Netherlands)'s research output growing?

Accepted Answer

Output in 2022-2025 was 17% lower than in 2018-2021.